Evidence map›Paper›PMID 32721945›Full record

ArticleJCI insight2020

Wiskott-Aldrich syndrome protein restricts cGAS/STING activation by dsDNA immune complexes.

Giulia Maria Piperno, Asma Naseem, Giulia Silvestrelli, Roberto Amadio, Nicoletta Caronni, Karla Evelia Cervantes-Luevano, Nalan Liv, Judith Klumperman, Andrea Colliva, Hashim Ali and 5 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. [Research progress on the cGAS-STING signaling pathway in immune-mediated inflammatory diseases in children].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 4 countries.

Giulia Maria PipernoInternational Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Asma NaseemInternational Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Giulia SilvestrelliInternational Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Roberto AmadioInternational Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Nicoletta CaronniInternational Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Karla Evelia Cervantes-LuevanoInternational Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Nalan LivSection Cell Biology, Center for Molecular Medicine, University Medical Center (UMC) Utrecht, Utrecht University, Utrecht, Netherlands.
Judith KlumpermanSection Cell Biology, Center for Molecular Medicine, University Medical Center (UMC) Utrecht, Utrecht University, Utrecht, Netherlands.
Andrea CollivaInternational Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Hashim AliInternational Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Francesca GrazianoInstitute Curie Laboratoire Immunité et Cancer - INSERM U932 Transport Intracellulaire et Immunité, Paris, France.
Philippe BenarochInstitute Curie Laboratoire Immunité et Cancer - INSERM U932 Transport Intracellulaire et Immunité, Paris, France.
Hans HaeckerDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Richard N HannaRespiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA.
Federica BenvenutiInternational Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
International Centre for Genetic Engineering and Biotechnology · ITInserm · FRUtrecht University · NLSt. Jude Children's Research Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysregulated sensing of self-nucleic acid is a leading cause of autoimmunity in multifactorial and monogenic diseases. Mutations in Wiskott-Aldrich syndrome protein (WASp), a key regulator of cytoskeletal dynamics in immune cells, cause autoimmune manifestations and increased production of type I IFNs by innate cells. Here we show that immune complexes of self-DNA and autoantibodies (DNA-ICs) contribute to elevated IFN levels via activation of the cGAS/STING pathway of cytosolic sensing. Mechanistically, lack of endosomal F-actin nucleation by WASp caused a delay in endolysosomal maturation and prolonged the transit time of ingested DNA-ICs. Stalling in maturation-defective organelles facilitated leakage of DNA-ICs into the cytosol, promoting activation of the TBK1/STING pathway. Genetic deletion of STING and STING and cGAS chemical inhibitors abolished IFN production and rescued systemic activation of IFN-stimulated genes in vivo. These data unveil the contribution of cytosolic self-nucleic acid sensing in WAS and underscore the importance of WASp-mediated endosomal actin remodeling in preventing innate activation.

Indexed as

ActinsAnimalsAutoantibodiesCells, CulturedCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseDendritic CellsDNAEndosomesImmunity, InnateInterferonsMembrane ProteinsMiceMice, Inbred C57BLNucleotidyltransferasesProtein Serine-Threonine KinasesSTING ProteinActinsAutoantibodiescGAS protein, mouseCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseDNAInterferonsMembrane ProteinsNucleotidyltransferasesProtein Serine-Threonine KinasesSting1 protein, mouseSTING ProteinTbk1 protein, mouseWas protein, mouseWiskott-Aldrich Syndrome ProteinCell BiologyDendritic cellsImmunologyInnate immunity

Identifiers

PMID32721945
PMCPMC7526445
OpenAlexW3045718054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.